ClinicalTrials.govpublic full text
Effect of Oral Galactose on Focal Segmental Glomerulosclerosis (FSGS) Permeability Factor
focal segmental glomerulosclerosis, fsgs, permeability factor, galactose, primary fsgs, resistant to immunosuppressive medication, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 885681
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.